A carregar...
Comprehensive Clinical Trial Data Summation for BRAF‐MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma
BACKGROUND. Immune checkpoint inhibitors, along with BRAF and MEK inhibitors, have dramatically changed the management of and outlook for patients with metastatic melanoma. Analyses of long‐term follow‐up data and subanalyses based on disease characteristics may inform clinical decision making. METH...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853121/ https://ncbi.nlm.nih.gov/pubmed/31064886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0876 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|